PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Highlights the firm's ability to meet near-term obligations and cover interest expenses. For conservative value investors, strong liquidity and coverage metrics are critical to avoid distress or forced dilution.
0.90
Current Ratio 0.5–0.75x Medical - Pharmaceuticals median of 1.58. Guy Spier would worry about potential short-term pinch.
0.47
Quick Ratio 0.5–0.75x Medical - Pharmaceuticals median of 0.91. Guy Spier would question if the company is at risk if bills come due rapidly.
0.40
Cash Ratio near Medical - Pharmaceuticals median of 0.38. Charlie Munger would see it as typical for the sector’s operating style.
88.55
Interest coverage of 88.55 versus zero Medical - Pharmaceuticals median. Walter Schloss would verify if our debt service capacity provides advantages.
1.34
Short-term coverage of 1.34 versus zero Medical - Pharmaceuticals median. Walter Schloss would verify if our cash flow management provides advantages.